The Answer is Simpler: The real cost of change
Understanding the total impact on workflow and improved efficiencies. Discover how it’s Simpler with Cepheid. Learn More
Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
CAP TODAY
New CAP PT/EQA program for POC troponin I
Aug. 5, 2025—The CAP announced in June a new proficiency testing/external quality assessment program for point-of-care high-sensitivity troponin I.
Roche gets clearance for Cobas Respiratory 4-flex
Aug. 4, 2025—Roche announced FDA 510(k) clearance for its Cobas Respiratory 4-flex assay.
FIGO endometrial cancer staging, 2 years in
April 2025—The updated International Federation of Gynecology and Obstetrics (FIGO)2023 staging system for endometrial cancer introduces significant changes …
Clinisys acquires Orchard Software
July 30, 2025—Clinisys has acquired Orchard Software from investment firm Francisco Partners, which bought Orchard in 2019.
Ascentry debuts at ADLM 2025
July 29, 2025—Ascentry, formerly BYG4lab, officially debuted at the Association for Diagnostics and Laboratory Medicine annual meeting (Chicago, July 27–31).
Seegene unveils CURECA–100% unattended PCR automation
Seegene introduced CURECA, a fully automated PCR solution that processes diverse specimen types (urine, blood, sputum, and stool) and performs the entire PCR workflow from sample loading to result. CURECA performs the entire PCR testing process without any human intervention, enabling nonstop operation, 24 hours a day, seven days a week. CURECA automatically stops and refills consumables and transfers testing plates to the next step. CURECA configuration can be tailored to specific laboratories that demand particular test types and have space constraints. CURECA offers flexibility in diagnostics, from small-scale to large-scale testing, enabling broad coverage of diseases.
Roche receives CE mark for Elecsys pTau181
July 28, 2025—Roche has received the CE mark for its Elecsys pTau181 test to measure phosphorylated tau 181 protein, an indicator of amyloid pathology.
MeMed completes development of MeMed BV Flex
July 25, 2025—MeMed has completed its multiyear development of MeMed BV Flex, a next-generation test designed to expand the reach of MeMed BV into decentralized, CLIA-waived settings
Seegene to unveil fully automated PCR system at ADLM 2025
July 23, 2025—Seegene will unveil its fully automated PCR testing system, CURECA, and its data analytics platform, Stagora, at the Association for Diagnostics and Laboratory Medicine annual meeting, July 27–31, in Chicago.